Compare KRMD & APYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KRMD | APYX |
|---|---|---|
| Founded | 1980 | 1982 |
| Country | United States | United States |
| Employees | N/A | 205 |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 189.3M | 169.6M |
| IPO Year | 2019 | 1995 |
| Metric | KRMD | APYX |
|---|---|---|
| Price | $3.86 | $3.90 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | $6.50 | $6.50 |
| AVG Volume (30 Days) | 125.1K | ★ 221.1K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 53.85 | 19.40 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $41,127,366.00 | N/A |
| Revenue This Year | $20.32 | $11.93 |
| Revenue Next Year | $17.37 | $11.01 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 22.23 | N/A |
| 52 Week Low | $2.63 | $1.36 |
| 52 Week High | $6.61 | $4.50 |
| Indicator | KRMD | APYX |
|---|---|---|
| Relative Strength Index (RSI) | 41.93 | 53.69 |
| Support Level | N/A | $3.82 |
| Resistance Level | $4.34 | $4.28 |
| Average True Range (ATR) | 0.18 | 0.38 |
| MACD | -0.01 | 0.08 |
| Stochastic Oscillator | 6.82 | 68.79 |
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Surgical Aesthetics and Original Equipment Manufacturing (OEM). Its Surgical Aesthetics segment derives the majority of its revenue.